PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Diclofenac sodium - Pain & inflammation - musculoskeletal

PAD Profile : Diclofenac sodium - Pain & inflammation - musculoskeletal

Keywords :
NSAIDs, rheumatism, PNMP, osteoarthritis
Brand Names Include :
Voltarol, Defenac, Dicloflex, Flamrase, Diclozip, Fenactol, Diclomax, Motifene

Traffic Light Status

Status 1 of 4.

Status :
Green (see narrative)
Important
Formulations :
  • Tablets
Important Information :
Ibuprofen or naproxen are the preferred NSAIDS. Diclofenac for use if 1st-line options are ineffective / not tolerated. Restriced at Trusts to Rheumatology only.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 4.

Status :
Non Formulary
Important
Formulations :
  • Modified release capsules
  • Modified release tablets
Important Information :
Ibuprofen or naproxen are the preferred NSAIDS. Standard release diclofenac may be considered if 1st-line NSAIDs are ineffective / not tolerated.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
Comments :
No comments returned.
Documents :

Status 3 of 4.

Status :
Green
Formulations :
  • Suppositories
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 4 of 4.

Status :
Green (see narrative)
Important
Formulations :
  • Injection
Important Information :
Restricted to use when oral NSAIDs are not an option.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date
Safety Information
01 July 2022

Committee Recommendations

Date
Committee Name
Narrative
07 August 2019
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

A stepped approach to pain management is recommended. Paracetamol is considered a 1st line option for the treatment of pain. Consider initiation of  oral NSAID (ibuprofen or naproxen) as an adjunct to paracetamol if required.  Diclofenac or celecoxib (first line COX 2) may be considered as alternatives when ibuprofen and naproxen are ineffective / not tolerated. See the guidelines attached for further information

Associated BNF Codes

10. Musculoskeletal and Joint Diseases
10.01.01. Non-steroidal anti-inflammatory drugs
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More